Peter de Keizer

Associate Professor

Strategic program(s):

Contact

pkeizer@umcutrecht.nl

Pure profile

Recent publications

All publications

Identified senescence endotypes in aged cartilage are reflected in the blood metabolome Ilja Boone, Margo Tuerlings, Rodrigo Coutinho de Almeida, Johannes Lehmann, Yolande Ramos, Rob Nelissen, Eline Slagboom, Peter de Keizer, Ingrid Meulenbelt
GeroScience, 2024, vol. 46, p.2359-2369

Are immunosenescent T cells really senescent? Helena Slaets, Naomi Veeningen, Peter L.J. de Keizer, Niels Hellings, Sven Hendrix
Aging Cell, 2024, vol. 23

Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis Rebeca Uceda-Castro, Andreia S. Margarido, Lesley Cornet, Serena Vegna, Kerstin Hahn, Ji Ying Song, Diana A. Putavet, Mariska van Geldorp, Ceren H. Çitirikkaya, Peter L.J. de Keizer, Leon C. ter Beek, Gerben R. Borst, Leila Akkari, Olaf van Tellingen, Marike L.D. Broekman, Claire Vennin, Jacco van Rheenen
Cell Reports Medicine, 2022, vol. 3, p.1-28

Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling F Kruiswijk, S. C. Hasenfuss, R. Sivapatham, Marjolein P. Baar, D. Putavet, K. A T Naipal, N.J.F. van den Broek, W. Kruit, P.J. Spek, D.C. Gent, A B Brenkman, J. Campisi, B M T Burgering, Jan H. J. Hoeijmakers, P L J de Keizer
Oncogene, 2016, vol. 35, p.2166-77

Forkhead box o as a sensor, mediator, and regulator of redox signaling. P.L.J. de Keizer, B.M.T. Burgering, T.B. Dansen
Antioxidants & redox signaling, 2011, vol. 14, p.1093-1106

Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence P.L.J. de Keizer, L.M. Packer, A.A. Szypowska, P.E. Riedl-Polderman, N.J.F. van den Broek, A. de Bruin, T.B. Dansen, R. Marais, A.B. Brenkman, B.M.T. Burgering
Cancer Research, 2010, vol. 70, p.8526-8536

External positions

Managing Director, Founder - Statutair directeur (enkel bevoegd) + bedenken en coordineren onderzoek en ontwikkelingswerk - Cleara Biotech B.V. (indirect vanuit holding)